Search
Add Axios as your preferred source to
see more of our stories on Google.
On Monday, a woman in Seattle became America’s first human subject of a novel coronavirus vaccine trial. Dan and Axios' Bob Herman dig into the vaccine development process and why a young biotech company is leading the pack.
Go deeper: Inside vaccine-maker Moderna Therapeutics
